Home / Inspections / 807042

FDA Inspection 807042 — Synapse Biomedical Inc

Synapse Biomedical Inc — FEI 3005868392

The FDA completed an inspection of Synapse Biomedical Inc on November 5, 2012 in Oberlin, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 5, 2012
Fiscal Year
2013
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Oberlin, OH (United States)

Facility

Other inspections at this facility

  • 1195865 (NAI Wed Jan 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1130955 (OAI Wed Oct 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 906473 (VAI Fri Dec 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 644078 (VAI Thu Feb 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources